NEWS

The Biologics Manufacturing Centre (BMC) is proud to announce the participation of its Chief Executive Officer, Isabelle Caron, in the 2025 Annual Symposium of the Canadian Society for Pharmaceutical Sciences (CSPS).

As part of a panel discussion and Q&A session, Isabelle will join industry leaders and government representatives to explore a key issue: access to essential medicines and the role of biomanufacturing in Canada.

Panel Details:

Topic: Essential Medicines and Biomanufacturing in Canada
Moderator: Scott Campbell (API)

Panelists:

• Isabelle Caron (BMC and Co-Chair of the Canadian Chamber of Commerce Life Sciences Working Group)

• Rodrigo Arancibia (ISED)

• Sevag Sahakian (Moderna)

• Frédéric Ors (Aramis Biotechnologies)

This panel will be an opportunity to reflect on Canada’s ability to build a resilient biomanufacturing ecosystem and ensure a reliable domestic supply of essential medicines — a critical issue for national health security.

Join us on May 27, 2025, from 3:30 PM to 4:30 PM at Université de Montréal

Find the full program here.